Home / Business and Economy / IBM Stock Soars on Barclays Overweight Rating
IBM Stock Soars on Barclays Overweight Rating
1 Jun
Summary
- Barclays initiates IBM coverage with Overweight rating and $350 price target.
- IBM secures $1 billion from Commerce Department for quantum chip foundry.
- Company generated 9.7% revenue growth in the last twelve months.
Barclays initiated coverage on International Business Machines Corp. (IBM) with an Overweight rating and a $350 price target, citing its strong software segment and growth potential. The firm expects mid-single-digit organic revenue growth and margin leverage, positioning IBM as a stable earnings compounder with a quantum advantage.
IBM's software offerings, including Red Hat Enterprise Linux and OpenShift, cater to large, complex customers in hybrid cloud environments. Barclays noted that IBM's open-source approach fosters adoption among major clients seeking hybrid cloud solutions, mitigating AI-related risks.
Recent developments highlight IBM's strategic advancements. The company received a $46 million contract modification from the U.S. Department of War, increasing its total contract value to $155.5 million. Additionally, IBM was awarded $1 billion from the U.S. Department of Commerce under the Chips Act to establish a quantum chip foundry, matched by an additional $1 billion investment to create a new company, Anderon.
Analysts from RBC Capital and Stifel have reiterated positive ratings on IBM, emphasizing its leadership in open-source enterprise software and its strategic investments in quantum computing. These endorsements reflect confidence in IBM's technological direction and its ongoing engagement in significant government contracts.
